Alex Morgan

Alex is a Partner at Khosla Ventures with a focus in biotechnology, healthcare, data science, and AI/ML. He works on new investments and sits on the boards of many KV portfolio companies.

Alex’s education and training encompasses physics, biology, biomedical informatics, and medicine; he also held a postdoctoral fellowship in biochemistry and genomics. As a scientist, he has published more than 50 scientific articles (h-index 38), primarily at the intersection of computer science, biology, and healthcare. As an inventor, he has licensed IP to three companies. As an entrepreneur, he has been a co-founder or early employee at a range of startups. He is committed to increasing access to high quality healthcare, STEM education and entrepreneurship opportunities for the underserved and under-represented.

Early in his career Alex taught himself programming and joined the MITRE Corporation as an artificial intelligence research engineer. Subsequently, Alex went to graduate school at Stanford in biomedical informatics, where he worked with genomics data on applications for biomarker discovery and therapeutics development. At Stanford, he also initiated early clinical trials for digital health using connected devices including health wearables and AR/VR technologies..

Since 2015, Alex has been at KV working on evaluating deal flow and new investments, supporting portfolio companies, and company incubation/creation.

Alex holds an undergraduate degree in physics from Brandeis University and an MS in biology from Tufts University. He also holds an MS and Ph.D. in biomedical informatics as well an M.D. from Stanford University.

  • 50
    Scientific articles published
  • 38
    His h-index
Meet 17 medical doctors at VC firms like GV and Khosla Ventures who are investing in the next big healthcare startups
Business Insider
These startups are beating Elon Musk in the race to let you mind meld with your computer
Business Insider
Instigators of Change: How A Tough 2022 Could Reshape Biotech
Khosla Ventures